| P2093 | author name string | Jing Chen | |
| | Ying Zhang | |
| | Feng Zhou | |
| | Yancheng Xu | |
| | Yimeng Hu | |
| P2860 | cites work | Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. | Q50482649 |
| | Protective effect of verapamil on multiple hepatotoxic factors-induced liver fibrosis in rats | Q79559623 |
| | Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance | Q83864443 |
| | The inflammasomes | Q24304087 |
| | Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation | Q28390197 |
| | Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo | Q28585441 |
| | A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells | Q29547557 |
| | Thioredoxin-interacting protein links oxidative stress to inflammasome activation | Q29614471 |
| | Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 |
| | The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association | Q29617157 |
| | Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation | Q33755829 |
| | Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis | Q34586647 |
| | Inflammasome is a central player in the induction of obesity and insulin resistance | Q35216914 |
| | Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between azelnidipine and amlodipine on glucose tolerance and end | Q35231198 |
| | Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice | Q35535851 |
| | Preventing β-cell loss and diabetes with calcium channel blockers | Q35857734 |
| | NALP-3 inflammasome silencing attenuates ceramide-induced transepithelial permeability | Q35881730 |
| | The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). | Q35907960 |
| | Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease. | Q36289689 |
| | New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats | Q37040345 |
| | Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease. | Q37420086 |
| | The role of interleukins in insulin resistance and type 2 diabetes mellitus. | Q37462159 |
| | The NLRP3 inflammasome: a sensor for metabolic danger? | Q37675505 |
| | Current therapeutic strategies in non-alcoholic fatty liver disease. | Q37859419 |
| | Inflammasomes in liver diseases | Q38013465 |
| | Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. | Q38119937 |
| | NAFLD: a multisystem disease. | Q38446387 |
| | Inflammasomes in non-alcoholic fatty liver disease | Q38681178 |
| | Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. | Q38698442 |
| | Bee's honey attenuates non-alcoholic steatohepatitis-induced hepatic injury through the regulation of thioredoxin-interacting protein-NLRP3 inflammasome pathway | Q38858068 |
| | Quercetin and allopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipid accumulation in diabetic rats | Q39155883 |
| | Thioredoxin-interacting protein mediates ER stress-induced β cell death through initiation of the inflammasome | Q39299566 |
| | Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers | Q41867019 |
| | Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity | Q42703006 |
| | Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation | Q42706386 |
| | Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity | Q43200840 |
| | Hepatic progenitor cell inhibition during embryonic period with high dose verapamil; liable joint to the cancer therapy. | Q43768435 |
| | Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice | Q47371785 |
| | Carbachol ameliorates lipopolysaccharide-induced intestinal epithelial tight junction damage by down-regulating NF-κβ and myosin light-chain kinase pathways | Q48120530 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | verapamil | Q410291 |
| P304 | page(s) | 640 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in Endocrinology | Q27723680 |
| P1476 | title | Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein/NLRP3 Pathways | |
| P478 | volume | 9 | |